Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

World’s Largest Study on Sleep Apnea Suggests Apps Improve Patient Adherence

XTALKS VITALS NEWS

Sleep Apnea

This observational study followed patients using sleep apnea devices, which were remotely monitored by their physician, or by themselves.

Share this!

October 26, 2016 | by Sarah Hand, M.Sc.

According to the results of a 128,000-patient study conducted by ResMed, sleep apnea patients who use a self-management app in conjunction with positive airway pressure (PAP) are more likely to adhere to their therapy. ResMed is a global medical device company, focused on using cloud-based apps to help patients manage their chronic disease.

“This new study shows that online self-monitoring tools engage patients and significantly improve their compliance and adherence to treatment,” said ResMed Medical Director Dr. Adam Benjafield. “While our study focused on PAP users, we believe these results may be generalized more broadly in terms of the role online tools can have in improving medical treatment compliance overall.”

According to ResMed, poor patient adherence to treatment places an estimated $290 billion burden on the US healthcare system every year. Poor adherence increases the likelihood of disease progression, and these patients are more likely to be admitted to the hospital.



This observational study followed patients using sleep apnea devices, which were remotely monitored by their physician, or by themselves. ResMed’s myAir cognitive behavior-based app was used to monitor the patient’s adherence to the therapy.

Over 87 percent of PAP users were compliant when using myAir for self-monitoring, in conjunction with AirView for clinician remote monitoring. Patients who were only monitored using AirView showed 70 percent compliance to their therapy. Despite advances in continuous positive airway pressure (CPAP) therapy for sleep apnea patients, as few as 50 percent of people adhere to the therapy in the absence of digital monitoring.

“Half of all patients don't take their medications as prescribed, and we know that same statistic holds true for compliance with PAP therapy for sleep apnea,” said Benjafield. “The effects of poor treatment adherence are profound, not only for the number of people suffering due to poor medication adherence, but also in terms of emergency room visits, hospitalizations and their financial burden to the healthcare system.”

As a companion to AirView, myAir could help patients ensure they’re following the proper advice of their clinician on how to best manage their sleep apnea. ResMed will present further study data at this year’s American College of Chest Physicians (CHEST) annual meeting.


Keywords: Sleep Apnea, Patient Adherence, Medical Device


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Gilead’s Newest Hepatitis C Drug Gets FDA Approval

July 21, 2017 - Dominant player in the chronic hepatitis C virus (HCV) market Gilead has received US Food and Drug Administration (FDA) approval for its newest treatment, Vosevi.

Featured In: Pharmaceutical News


Detecting Alzheimer’s Biomarkers in the Blood Could Improve Early Diagnosis

July 20, 2017 - In an effort to improve rates of early diagnosis and intervention, researchers at Washington University in St. Louis have developed a blood test that can detect some of the hallmarks of Alzheimer’s disease.

Featured In: Biotech News


Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

Manufacturing Control Strategies: What Pharmaceutical and Biotech Companies Need to Know

REGISTER FOR THESE WEBINARS

Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned


EDC and eSource: Combined for Better Data and Faster Insights


Using Model Reduction to Bridge the Quality Systems Pharmacology-Pharmacometrics Divide


How to Maximize Your Non-GLP Toxicology Studies: A Guide for Optimal Design and Methodology


Copyright © 2016-2017 Honeycomb Worldwide Inc.